Severe hemorrhagic colitis caused by dasatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Shimokaze
Tomoyuki
T
Yamagata University School of Medicine, Department of Pediatrics, Yamagata 990-9585, Japan. simokaze@med.id.yamagata-u.ac.jp
Mitsui
Tetsuo
T
Takeda
Hiroaki
H
Kawakami
Takako
T
Arai
Takahiko
T
Ito
Masafumi
M
Iwaba
Akiko
A
Izumino
Hiroko
H
Takahashi
Noriyuki
N
Kanno
Miyako
M
Sendo
Dai
D
Hayasaka
Kiyoshi
K
D016026:Bone Marrow Transplantation; D002648:Child; D003092:Colitis / Q000139:chemically induced* / Q000188:drug therapy; D003113:Colonoscopy; D003131:Combined Modality Therapy; D000069439:Dasatinib; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D010677:Philadelphia Chromosome; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011505:Protein-Tyrosine Kinases / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D013844:Thiazoles / Q000009:adverse effects*
D011743:Pyrimidines; D013844:Thiazoles; D011505:Protein-Tyrosine Kinases; D000069439:Dasatinib